Sanofi: OpenAI's Research Agents Could Lead To Explosive Growth
Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.
pharmaphorum1d
Pharma partnerships: Sanofi experimenting with a new collaborative model
while 100% of my salary and all other compensations remain paid by Sanofi. The trade for Hemarina is to have a pharma background experienced competency ex gratia. It is ruled and governed by a ...